We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

VIA Pharmaceuticals Announces Funding for Pharmacogenomic Sub-Study on VIA-2291 ACS Trial

News   Oct 08, 2007

 
VIA Pharmaceuticals Announces Funding for Pharmacogenomic Sub-Study on VIA-2291 ACS Trial
 
 
 

RELATED ARTICLES

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Obesity May be Predicted by Oral Bacteria in Young Children

News

The composition of oral microbiota, including beneficial bacteria, residing in the mouth of two-year-old children may predict their weight gain.

READ MORE

30% of Human Genes Have Never Been the Focus of a Scientific Study

News

Historical bias is a key reason biomedical researchers continue to study the same 10 percent of all human genes whose sequences are known while ignoring many genes known to play roles in disease, according to a new Northwestern University study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE